A Message from Our CEO
Welcome to Arabic Group for Scientific Research (A.G.S.R) !

  • As the CEO of AGSR, I am proud to lead a team of dedicated professionals committed to advancing scientific research and improving lives. Since our inception, we have been at the forefront of innovation, pushing the boundaries of what's possible to bring hope and bright future.
  • From our dedicated team of researchers and scientist team to our cutting-edge technology,  we are united in our mission to deliver the highest standard of care and to make a meaningful difference in the lives of those we serve.
  • Through the remarkable potential of autologous bone marrow therapy, we utilize the body's own regenerative capacity to target diseases at their source, offering personalized treatment options that hold the promise of renewed health and vitality.
  • As CEO, I am incredibly proud of what we have accomplished, but I am even more excited about what lies ahead. Together, we will continue to push the boundaries of innovation, to explore new frontiers in research.
Mobirise

History

1

2023

The Founding of Arabic Group for Scientific Research (A.G.S.R)

Embarking on a journey fueled by passion and innovation, A.G.S.R was established with a clear vision: to pioneer advancements in different fields. We are started with medical advancements through the transformative potential of bone marrow cell therapy. Driven by a team of dedicated scientists and medical professionals, our company's inception marked the beginning of a groundbreaking endeavor to harness the regenerative power of bone marrow cells and revolutionize the treatment landscape for patients worldwide.
2

2023

Bridging Borders: Collaborative Research Initiatives in this Project.

Drawing upon the wealth of knowledge and resources across multiple universities and laboratories in Lebanon and Iraq, our collaborative research project brings together in a unified effort to explore researches in different fields and the therapeutic potential of bone marrow cell therapy. 
3

Feb 2024

Ensuring Quality in Bone Marrow Therapy

A.G.S.R has achieved ISO certification for our Quality Management System (QMS) in bone marrow therapy. This  certification reflects our unwavering commitment to maintaining the highest standards of quality, safety, and effectiveness in every aspect of our bone marrow therapy treatments.

To pioneer groundbreaking advancements in healthcare and technology, fostering a healthier, more sustainable future for all.

Our Vision

- Innovation               
 - Integrity
- Excellence                 
- Collaboration

Our Values

Our Certificates

Our ISO certification attests to our commitment to quality management systems, ensuring that our autologous bone marrow cell therapy, as a treatment modality for benign diseases, meets rigorous standards for safety, efficacy, and patient satisfaction.

Feb 16, 2024 -
Feb 14, 2025

Mobirise
Quality Management System

Autologous bone marrow cell therapy as treatment modality in the treatment of benign diseases

Arabic Group for Scientific Research
QUICK LINK
Medical
Engineering

© Copyright 2024 - All Rights Reserved